|
Sonic Healthcare USA signs licence for PromarkerD in the US
|
10 May 2023 at 12:05pm
|
|
Trading Halt
|
8 May 2023 at 9:40am
|
|
World Endometriosis Congress - New diagnostic test showcased
|
5 May 2023 at 8:45am
|
|
Canagliflozin lowers PromarkerD DKD risk prediction scores
|
3 May 2023 at 8:40am
|
|
Notification of cessation of securities - PIQ
|
1 May 2023 at 5:25pm
|
|
Exercise of Options
|
1 May 2023 at 9:45am
|
|
Application for quotation of securities - PIQ
|
1 May 2023 at 9:40am
|
|
March 2023 Quarterly Activities Report and Appendix 4C
|
27 April 2023 at 8:25am
|
|
Clinical Advisory Board expanded for PromarkerD USA rollout
|
26 April 2023 at 9:50am
|
|
Proteomics renews ISO 13485 and ISO 17025 accreditations
|
17 April 2023 at 8:45am
|
|
Notification of cessation of securities - PIQ
|
14 April 2023 at 11:25am
|
|
Exercise of Options
|
27 March 2023 at 5:35pm
|
|
Application for quotation of securities - PIQ
|
27 March 2023 at 5:35pm
|
|
New endometriosis test presented at international conference
|
24 March 2023 at 6:05pm
|
|
Trading Halt
|
24 March 2023 at 9:35am
|
|
Exercise of Options
|
17 March 2023 at 1:40pm
|
|
Application for quotation of securities - PIQ
|
17 March 2023 at 1:40pm
|
|
Proteomics International Webinar and Q&A
|
16 March 2023 at 5:45pm
|
|
PromarkerD application for Australian MBS to be resubmitted
|
15 March 2023 at 3:30pm
|
|
US update - PromarkerD licensing negotiations
|
1 March 2023 at 9:35am
|
|
Appendix 4D and Interim Financial Report
|
27 February 2023 at 1:30pm
|
|
Distribution agreement for PromarkerD in Britain extended
|
15 February 2023 at 8:25am
|
|
Exercise of Options
|
14 February 2023 at 1:20pm
|
|
Application for quotation of securities - PIQ
|
14 February 2023 at 1:20pm
|
|
Exercise of Options
|
7 February 2023 at 10:20am
|
|
Application for quotation of securities - PIQ
|
7 February 2023 at 10:15am
|
|
Investor presentation - Euroz Hartleys Healthcare Forum
|
2 February 2023 at 8:40am
|
|
December 2022 Quarterly Activities Report and Appendix 4C
|
31 January 2023 at 10:05am
|
|
Letter of intent with Sonic Healthcare USA extended
|
31 January 2023 at 9:45am
|
|
Exercise of Options
|
27 January 2023 at 8:45am
|
|
Application for quotation of securities - PIQ
|
27 January 2023 at 8:45am
|
|
Exercise of Options
|
19 January 2023 at 12:30pm
|
|
Application for quotation of securities - PIQ
|
19 January 2023 at 12:20pm
|
|
Exercise of Options
|
11 January 2023 at 12:45pm
|
|
Application for quotation of securities - PIQ
|
11 January 2023 at 12:45pm
|
|
Letter of intent with Sonic Healthcare USA extended
|
5 January 2023 at 8:45am
|
|
CPT PLA reimbursement code approved in US for PromarkerD
|
3 January 2023 at 8:45am
|
|
UK NICE publishes Medtech Innovation Briefing on PromarkerD
|
14 December 2022 at 8:40am
|
|
Change of Directors' Interest Notices
|
24 November 2022 at 5:55pm
|
|
Notification regarding unquoted securities - PIQ
|
24 November 2022 at 5:45pm
|
|
Completion of Tranche 2 of Placement
|
24 November 2022 at 5:35pm
|
|
Application for quotation of securities - PIQ
|
24 November 2022 at 5:30pm
|
|
New Constitution
|
24 November 2022 at 5:25pm
|
|
Results of Meeting
|
24 November 2022 at 3:10pm
|
|
AGM Chairman's Address and Investor Presentation
|
24 November 2022 at 12:50pm
|
|
Notification regarding unquoted securities - PIQ
|
22 November 2022 at 2:59pm
|
|
Issue of Equity Incentives to Employees
|
22 November 2022 at 2:50pm
|
|
PromarkerD patent granted in Hong Kong
|
11 November 2022 at 8:40am
|
|
Investor Presentation to the Emerging ASX Gems Conference
|
4 November 2022 at 8:40am
|
|
Proteomics to present at the Emerging ASX Gems Conference
|
3 November 2022 at 8:35am
|
Proteomics International Laboratories